Trial intelligence / Profile preview

Ertapenem pharmacokinetics in mechanically ventilated burn patients

2009-012370-12Phase 4Active

Sponsor
CHU de Nantes
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of ertapenem in burn injury and Early infection, sponsored by CHU de Nantes. Primary endpoints: Total serum ertapenem concentrations at steady state, Total urinary ertapenem concentrations and 2 more. Started May 2009; status: active.

02

Drugs

ertapenem
03

Conditions

burn injuryEarly infection

Beyond the preview

Go deeper on 2009-012370-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-012370-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call